Premium Nahrungsergänzungsmittel | artgerecht

Anticoagulant Therapy: How It Works and When

Anticoagulant therapy is a medical treatment that reduces the blood´s ability to clot. It is used to prevent or treat conditions such as deep vein thrombosis, pulmonary embolism, and stroke.

Regular tips about health Regular tips about health

Things worth knowing about "Anticoagulant Therapy"

Anticoagulant therapy is a medical treatment that reduces the blood´s ability to clot. It is used to prevent or treat conditions such as deep vein thrombosis, pulmonary embolism, and stroke.

What Is Anticoagulant Therapy?

Anticoagulant therapy refers to the use of medications that inhibit blood clotting. These drugs, known as anticoagulants or informally as blood thinners, work by interfering with the coagulation cascade – the series of biochemical steps that lead to the formation of a blood clot (thrombus). The therapy is used both to prevent clots from forming (prophylaxis) and to stop existing clots from growing larger (treatment).

Indications – When Is It Used?

Anticoagulant therapy is prescribed in a variety of clinical situations, including:

Deep vein thrombosis (DVT): Blood clot formation in the deep veins, usually in the legs
Pulmonary embolism: Blockage of blood vessels in the lungs by a clot
Atrial fibrillation: An irregular heart rhythm associated with an increased risk of stroke
Mechanical heart valves: Artificial valves that increase the risk of clot formation
Stroke prevention: Reducing the risk of recurrent stroke in high-risk patients
Postoperative prophylaxis: After major surgeries, particularly hip or knee replacements

Mechanism of Action

Different classes of anticoagulants target different steps in the clotting process:

Vitamin K Antagonists (VKA)

Drugs such as warfarin or phenprocoumon block the liver from producing vitamin K-dependent clotting factors (II, VII, IX, and X). Because their effect is delayed, patients require regular blood monitoring using the INR (International Normalized Ratio) to ensure the dose is within the therapeutic range.

Heparins

Unfractionated heparin (UFH) and low molecular weight heparins (LMWH) enhance the activity of antithrombin, a natural clotting inhibitor in the body, thereby inactivating several clotting factors. Heparins are administered by injection (subcutaneous or intravenous) and are commonly used in hospital settings.

Direct Oral Anticoagulants (DOACs)

These newer agents selectively block specific clotting factors:

Factor Xa inhibitors: Rivaroxaban, Apixaban, Edoxaban
Direct thrombin inhibitors: Dabigatran

DOACs are taken by mouth and generally do not require routine blood monitoring, making them more convenient for long-term use.

Dosage and Administration

The appropriate dosage of anticoagulants depends on the indication, the patient's body weight, kidney function, age, and other individual factors. Vitamin K antagonists require regular dose adjustments to maintain the target INR range. DOACs are typically given at fixed doses, though reductions may be needed in patients with impaired kidney function.

Side Effects and Risks

The primary risk of anticoagulant therapy is bleeding. This can range from minor issues such as nosebleeds or bruising to serious events such as gastrointestinal bleeding or intracranial hemorrhage. Other potential side effects include:

Allergic reactions
With heparins: Heparin-induced thrombocytopenia (HIT) – a paradoxical drop in platelet count that paradoxically increases clotting risk
With VKAs: interactions with vitamin K-rich foods (e.g., spinach, broccoli, kale) and numerous medications

Monitoring and Safety

Patients on anticoagulant therapy require regular medical follow-up. Key safety measures include:

Routine blood tests (INR monitoring for VKA; kidney function tests for DOACs)
Patient education on signs of bleeding and when to seek medical attention
Caution around injuries, surgeries, and invasive procedures
Awareness of drug-drug and drug-food interactions

Antidotes – Reversal Agents

Specific reversal agents are available for some anticoagulants and can be used in cases of life-threatening bleeding:

Vitamin K and prothrombin complex concentrate (PCC) for VKAs
Protamine sulfate for heparin
Idarucizumab (Praxbind) for dabigatran
Andexanet alfa for factor Xa inhibitors

References

Steffel J et al. - The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants. European Heart Journal, 2018.
Kearon C et al. - Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. CHEST Journal, 2016.
World Health Organization (WHO) - Cardiovascular diseases: prevention and treatment guidelines. WHO Geneva, 2023.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.

Most read entries

3 Posts in this encyclopedia category